HealthVerity + AWS: Pathways to success in AI – Webinar recap
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Given its role at the intersection of novel real-world data and emerging technologies, HealthVerity...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
HealthVerity was honored to have been chosen as the first partner in Inovalon’s newly established...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data aggregators, once considered reliable partners, are now liabilities facing significant challenges, including cyber threats, data restrictions, and opaque ...